Holen Sie sich die Stockscreener-App
1.76
1.12%
-0.02
Schlusskurs vom Vortag:
$1.78
Offen:
$1.77
24-Stunden-Volumen:
3.60M
Relative Volume:
1.07
Marktkapitalisierung:
$1.13B
Einnahmen:
$2.45B
Nettoeinkommen (Verlust:
$-137.40M
KGV:
-8.5395
EPS:
-0.2061
Netto-Cashflow:
$333.90M
1W Leistung:
+9.32%
1M Leistung:
-8.81%
6M Leistung:
-35.53%
1J Leistung:
-51.91%
1-Tages-Spanne:
$1.72
$1.82
1-Wochen-Bereich:
$1.70
$1.85
52-Wochen-Spanne:
$1.42
$3.87
Clarivate Plc Stock (CLVT) Company Profile
Firmenname
Clarivate Plc
Sektor
Telefon
(207) 433-4000
Adresse
4TH FLOOR, ST. PAUL'S GATE, ST. HELIER
Compare CLVT vs IBM, ACN, INFY, CTSH, FISV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLVT
Clarivate Plc
|
1.76 | 1.13B | 2.45B | -137.40M | 333.90M | -0.2061 |
IBM
International Business Machines Corp
|
251.46 | 236.91B | 68.91B | 10.73B | 12.26B | 11.31 |
ACN
Accenture Plc
|
240.26 | 147.03B | 73.10B | 7.94B | 12.58B | 12.52 |
INFY
Infosys Ltd Adr
|
12.75 | 51.64B | 20.21B | 3.33B | 3.87B | 0.8084 |
CTSH
Cognizant Technology Solutions Corp
|
69.55 | 31.33B | 21.41B | 2.23B | 2.47B | 4.6058 |
FISV
Fiserv Inc
|
48.21 | 25.64B | 21.09B | 3.22B | 4.17B | 5.8948 |
Clarivate Plc Stock (CLVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-12-17 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-09-03 | Eingeleitet | Wolfe Research | Peer Perform |
| 2025-07-18 | Herabstufung | Jefferies | Buy → Hold |
| 2024-11-06 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-15 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2023-10-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-09-08 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-08-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-08-04 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-06-13 | Eingeleitet | Oppenheimer | Outperform |
| 2023-03-15 | Fortgesetzt | BofA Securities | Neutral |
| 2023-02-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-13 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-02-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-12-21 | Fortgesetzt | Citigroup | Buy |
| 2021-12-13 | Fortgesetzt | Goldman | Buy |
| 2021-08-16 | Eingeleitet | BofA Securities | Buy |
| 2021-08-04 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-03-31 | Eingeleitet | Jefferies | Buy |
| 2021-03-11 | Fortgesetzt | Citigroup | Buy |
| 2021-03-08 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Clarivate Plc Aktie (CLVT) Neueste Nachrichten
Sterne, Kessler, Goldstein & Fox and Clarivate plc Announce Partnership to Develop Ai-Enhanced Patent Workflow Solutions - www.marketscreener.com
Clarivate, Sterne Kessler Collaborate on AI-Enhanced Patent Workflows - marketscreener.com
Clarivate, Sterne Kessler Collaborate on AI-Enhanced Patent Workflows - Yahoo Finance
Clarivate (NYSE:CLVT) Shares Up 7.8%Should You Buy? - MarketBeat
Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions - Yahoo Finance UK
After a $600M healthcare sale, Clarivate (CLVT) anticipates partial debt redemptions. - Stock Titan
Clarivate PLC (NYSE:CLVT) Stock Rated "Reduce" by Sell-Side Analysts - MarketBeat
Latham Advises on Financing for Altaris’ Completed Acquisition of Clarivate’s Life Sciences & Healthcare Business - Latham & Watkins LLP
Form 4 CLARIVATE PLC For: 9 October By Investing.com - Investing.com Nigeria
Clarivate (NYSE:CLVT) Stock Jumps 4.4%Time to Buy? - MarketBeat
Clarivate (NYSE:CLVT) Stock Forecast & Analyst Predictions - Simply Wall Street
Clarivate Divests Life Sciences Unit to Refocus Core - The Globe and Mail
Clarivate completes $600m life sciences unit sale to Altaris - Investing.com
Altaris Completes Acquisition of Clarivate’s Life Sciences & Healthcare Business - Clarivate
Clarivate Divests Life Sciences Unit to Refocus Core - TipRanks
Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment - marketscreener.com
Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment - Yahoo Finance
CLARIVATE PLC Announces Termination of Henry Levy's Employment as President, Life Sciences & Healthcare, Effective October 6, 2026 - www.marketscreener.com
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation - Morningstar
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation - PR Newswire
What Does Clarivate (NYSE:CLVT) New Low Signal on NYSE? - Kalkine Media
Clarivate (NYSE:CLVT) Hits New 12-Month LowWhat's Next? - MarketBeat
Clarivate: Pricing The Worst, As The Business Still Has Chances (NYSE:CLVT) - Seeking Alpha
Clarivate Stock Price Forecast. Should You Buy CLVT? - StockInvest.us
Shares replace a $51,250 cash retainer for Clarivate (CLVT) director Andrew Miles Snyder. - Stock Titan
Clarivate (NYSE:CLVT) Stock Falls 5.9%Here's Why - MarketBeat
Clarivate (CLVT) Institutional Ownership 2026 $CLVT - MarketBeat
Clarivate : IPfolio Selected by Topcon - marketscreener.com
Clarivate Plc stock hits 52-week low at 1.65 USD By Investing.com - Investing.com Nigeria
Clarivate Plc stock hits 52-week low at 1.65 USD By Investing.com - Investing.com South Africa
Clarivate Plc stock hits 52-week low at 1.65 USD - Investing.com
Clarivate (NYSE:CLVT) Hits New 1-Year LowWhat's Next? - MarketBeat
Clarivate PLC (16A.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Clarivate Plc Announces Completion and Results of Debt Tender Offer by Subsidiary - Kalkine Media
Clarivate announces $75M accepted tender for 3.875% notes due 2028, proration 11.3% - TradingView
Holders tendered $665M in notes to a Clarivate (CLVT) subsidiary. Only a portion was accepted. - stocktitan.net
Clarivate Plc (CLVT) Finalizes Cash Tender for 2028 Notes Up to $75M - TradingView
Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities - PR Newswire
Form 8K CLARIVATE PLC For: 23 September By Investing.com - Investing.com Nigeria
Clarivate Plc (CLVT) Sets Pricing Terms for $75M Tender of 2028 Notes - TradingView
Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities - PR Newswire
Clarivate to Report Third Quarter 2026 Results on November 3, 2026 - finance.yahoo.com
Clarivate schedules its next results call for Nov. 3 - Stock Titan
Clarivate launches tender offer for up to $75M of 3.875% secured notes due 2028 - tradingview.com
Clarivate (CLVT) starts $75M debt buyback - Stock Titan
Clarivate Plc (NYSE:CLVT) Launches Cash Tender for 2028 Notes, Capped at $75M - tradingview.com
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities - PR Newswire
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs - PR Newswire
22 researchers behind GLP-1 medicines earn Clarivate’s Nobel-class honor - Stock Titan
Clarivate Subsidiary Launches Cash Tender Offer for Senior Secured Notes - Yahoo Finance
Finanzdaten der Clarivate Plc-Aktie (CLVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clarivate Plc-Aktie (CLVT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cornick Kenneth L. | Director |
Aug 07 '26 |
Buy |
1.85 |
250,000 |
462,500 |
2,000,000 |
| Snyder Andrew Miles | Director |
Aug 03 '26 |
Sale |
1.94 |
2,489,618 |
4,829,859 |
3,856,597 |
| Andrew Miles Snyder | Director |
Aug 03 '26 |
Proposed Sale |
1.98 |
2,489,618 |
4,929,444 |
0 |
| BAR VEINSTEIN | Officer |
Dec 01 '25 |
Proposed Sale |
3.74 |
309,902 |
1,160,273 |
0 |
| Veinstein Bar | President, A&G |
Dec 01 '25 |
Sale |
3.74 |
309,902 |
1,159,033 |
848,811 |
| Cornick Kenneth L. | Director |
Nov 10 '25 |
Buy |
3.45 |
100,000 |
345,000 |
1,100,000 |
| Cornick Kenneth L. | Director |
Nov 03 '25 |
Buy |
3.52 |
225,000 |
792,000 |
1,000,000 |
| Cornick Kenneth L. | Director |
Oct 31 '25 |
Buy |
3.38 |
500,000 |
1,690,000 |
775,000 |
| Snyder Andrew Miles | Director |
Oct 31 '25 |
Buy |
3.33 |
1,460,000 |
4,861,800 |
2,247,510 |
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):